WaveMan
WaveMan · Company
ACNT · Ascent Industries Co.
> Search tickers & screens ⌘K
LIVE
← All companies

ACNT Ascent Industries (ACNT) Insider Trading, Ownership & Congress Trades

Pharma & Biotech · Chemicals & allied products · CIK 0000095953
Quote by TradingView
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
36
13F, latest reported quarter

What the filings say about ACNT

Insiders, 180 days
-$21.1K net sold
1 seller · 0% of sales under a 10b5-1 plan

Ascent Industries insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

Over the last 180 days, ASCENT INDUSTRIES CO. insiders sold a net $21.1K of stock across 61 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.

Insider
Filed
Shares
Value
Since filing
Mazzaferro Aldo John Jr
Director
SELL
2026-06-29 SECtraded 2026-06-26
1,500
$21.1K
-10.0%
Context
  • 1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on Nov 11, 2022.
  • The trade is 8.2% of the 18,362 shares held after it.
  • No other insider sold within 30 days.
  • 36 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Mazzaferro Aldo John Jr sold about $21.1K of ACNT on Jun 26, 2026; 36 funds added in the latest 13F quarter.
Kitchen John Bryan
Chief Executive Officer
BUY
2026-03-18 SECtraded 2026-03-17
145
$1.9K
+8.6%
Context
  • 4 earlier Form 4 trades (code P or S) here by this insider (4 buys), the last on Dec 6, 2024.
  • -0.6% median (+2.8% mean) 90-day return after 4 previous buys.
  • The trade is 0.2% of the 72,535 shares held after it.
  • 1 other insider bought within 30 days.
  • 36 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer Kitchen John Bryan bought about $1.9K of ACNT on Mar 17, 2026; 1 other insider bought within 30 days and 36 funds added in the latest 13F quarter.
Kitchen John Bryan
Chief Executive Officer
BUY
2026-03-18 SECtraded 2026-03-17
7,450
$96.7K
+8.6%
Context
  • 4 earlier Form 4 trades (code P or S) here by this insider (4 buys), the last on Dec 6, 2024.
  • -0.6% median (+2.8% mean) 90-day return after 4 previous buys.
  • The trade is 9.3% of the 79,985 shares held after it.
  • 1 other insider bought within 30 days.
  • 36 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer Kitchen John Bryan bought about $96.7K of ACNT on Mar 17, 2026, the largest insider purchase at the company on our record; 1 other insider bought within 30 days and 36 funds added in the latest 13F quarter.
Pan Anthony X
BUY
2026-03-09 SECtraded 2026-03-06
1,900
$25.2K
+4.1%
Context
  • 28 earlier Form 4 trades (code P or S) here by this insider (28 buys), the last on May 14, 2025.
  • +12.2% median (+15.2% mean) 90-day return after 18 previous buys.
  • The trade is 9.9% of the 19,151 shares held after it.
  • 1 other insider bought within 30 days.
  • 36 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider Pan Anthony X bought about $25.2K of ACNT on Mar 6, 2026; 1 other insider bought within 30 days and 36 funds added in the latest 13F quarter.
Pan Anthony X
BUY
2026-03-09 SECtraded 2026-03-06
1,500
$20.0K
+4.1%
Context
  • 28 earlier Form 4 trades (code P or S) here by this insider (28 buys), the last on May 14, 2025.
  • +12.2% median (+15.2% mean) 90-day return after 18 previous buys.
  • The trade is 7.3% of the 20,651 shares held after it.
  • 1 other insider bought within 30 days.
  • 36 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider Pan Anthony X bought about $20.0K of ACNT on Mar 6, 2026; 1 other insider bought within 30 days and 36 funds added in the latest 13F quarter.
61 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to see 56 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
net -$21.1K over 180 days
more than 60% of Pharma & Biotech
Congress
no House purchase disclosed in the last 12 months
Funds
36 funds bought in last quarter
below 59% of Pharma & Biotech
Revenue
-7.2% year over year
below 64% of Pharma & Biotech
Margin
1.2% net margin
more than 74% of Pharma & Biotech
Buybacks
$6.8M repurchased, FY to 2026-06-30
below 77% of Pharma & Biotech
Short interest
2.1% of the float short (float per yahoo 2026-10-26) · 5.1 days to cover · settled 2026-09-30
below 68% of Pharma & Biotech
What changed in the last 30 days
Nothing new filed in the last 30 days

Watch ACNT

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+13.1%12M
+0%+16%+32%+49%2025-102025-122026-022026-042026-062026-082026-10 2026-03-17 · Kitchen John Bryan bought $96.7K2026-03-06 · Pan Anthony X bought $25.2K2026-06-26 · Mazzaferro Aldo John Jr sold $21.1K2026-03-06 · Pan Anthony X bought $20.0K2026-03-17 · Kitchen John Bryan bought $1.9K
Insider buyInsider sell
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns ACNT: institutional holders (13F)

13F holdings, latest reported quarter
Mink Brook Asset Management LLC
884,483 sh
$13.3M
VANGUARD CAPITAL MANAGEMENT LLC
345,062 sh
$5.2M
BARD ASSOCIATES INC
321,984 sh
$4.8M
DIMENSIONAL FUND ADVISORS LP
283,567 sh
$4.3M
RENAISSANCE TECHNOLOGIES LLC
279,202 sh
$4.2M

Congress trades in ACNT

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

ACNT planned insider sales (Form 144)

No planned-sale notices
No insider has filed to sell. Watch this after a run-up.

ACNT mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).
Gabelli Global Mini Mites Fund
$135.3K position · as of 2026-06-30
0.5%
Dunham Small Cap Value Fund
$260.1K position · as of 2026-07-31
0.3%
Heartland Value Fund
$3.0M position · as of 2026-06-30
0.3%
Ultra-Small Company Market Fund
$233.7K position · as of 2026-06-30
0.2%
U.S. Small Cap Equity Fund
$640.1K position · as of 2026-07-31
0.1%
U.S. Small Cap Equity Fund
$127.8K position · as of 2026-06-30
0.1%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio
Executive pay vs shareholder return · Christopher Hutter
CEO pay, headline and as actually paid, against the company's return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2023
$35.6K
-$105.3K
$327.9K
+10%
n/a
2022
$1.6M
$767.5K
$464.7K
-47%
n/a
2021
$385.6K
$904.8K
$469.1K
+111%
n/a
Tagged by the company under SEC Item 402(v). Returns are cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows a net $21.1K sold by insiders over 180 days, 36 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
UTHRCPIXMRNAREGNLLYALNYMDGLCITRDNAVRTXNUVLTWST

ACNT financials

Revenue growth
-7.2%
XBRL, annual
Net margin
1.2%
Complaints, 90 days
18
-40.0% YoY · CFPB
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Net margin, TTM
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Free cash flow, TTM
-$8.4M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Debt to equity
0.00x
LongTermDebt as filed 2024-12-31 (18 months older than the period end) (includes the current portion); equity 2026-06-30
Cash flow to debt
n/a
no debt to cover
Return on equity
-5.2%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets
-3.9%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on invested capital
n/a
tax provision or pre-tax income not filed for the four quarters
Return on capital employed
-4.9%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Enterprise value
$93.8M
market value at close 2026-10-26 on 2026-07-31 shares, plus LongTermDebt as filed 2024-12-31 (18 months older than the period end) (includes the current portion), minus cash 2026-06-30
FCF yield
-6.9%
TTM free cash flow over market value at close 2026-10-26
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-122022-12
Revenue$74.9M$177.9M$193.2M$414.1M
Gross profit$17.2M$10.7M$1.5M$43.3M
Operating income-$7.0M-$10.8M-$37.4M$14.5M
Net income$867.0K-$13.6M-$26.6M$22.1M
EPS (diluted)0.09-1.35-2.632.12
Operating cash flow-$519.0K$14.7M$23.1M$5.6M
Cash$57.6M$16.1M$1.9M$1.4M
Long-term debtn/a$0$0$69.1M
Buybacks$9.1M$1.0M$1.3M$1.3M
SEC XBRL, fiscal years, as known on 2026-10-27

ACNT Stock Sonar score 6/7 axes

Find similar shapesCompare

ACNT ranks highest on financial health (99th percentile) and profitability (80th), and lowest on insider conviction (29th), among Pharma & Biotech peers.

ProfitHealthGrowthInsidersInstitutionsRisk
Profitability
80
Inputs
  • Return on equity-5.2% · 79 pct, sector of 545
  • Return on assets-3.9% · 79 pct, sector of 691
  • Return on invested capitaltax provision or pre-tax income not filed for the four quarters
  • Return on capital employed-4.9% · 82 pct, sector of 576
Financial health
100
Inputs
  • Debt to equity0.00x · 100 pct, sector of 352
  • Cash flow to debtno debt to cover
Growth
36
Inputs
  • Revenue growth, YoY-7.2% · 36 pct, sector of 505
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
29
Inputs
  • Net Form 4 buying (codes P and S), 180d-$21K · 58 pct, sector of 428
  • Insider buyers, 180d0 · 0 pct, sector of 437
Institutional and government
41
Inputs
  • Funds adding, latest quarter36 · 41 pct, sector of 698
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
38
Inputs
  • Short interest, % of float+2.1% · 73 pct, sector of 813
  • Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
  • EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
  • New text in Risk Factors, latest 10-K+60.7% · 3 pct, sector of 511
1 not measured: US patents
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

ACNT filings, in plain words

Are Ascent Industries insiders buying or selling ACNT?

In the 180 days to 2026-10-27, Ascent Industries insiders were net sellers, a net $21.1K across purchases and sales reported on Form 4, by 1 seller.

Read the full summary

In the 180 days to 2026-10-27, Ascent Industries insiders were net sellers of ACNT, a net $21.1K across purchases and sales reported on Form 4 by 1 seller. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies